Abstract
The rearrangement of a new α-phenyl-N -(2-aminofluorenyl)nitrone (8 ) to a new ultimate carcinogen, N -acetoxy-N- benzoyl-2-aminofluorene (9 ) is achieved in a lead tetraacetate (LTA) oxidation reaction. Compound 9 reacts with deoxyguanosine (dG) at pH 7.0 to give N -(benzoyl)-N -(deoxyguanosin-8-yl)-2-aminofluorene (10 ). Subsequent debenzoylation with the heterogeneous system (sodium carbonate/methanol)
leads to the C8-adduct, N -(2′-deoxyguanosin-8-yl)-2-aminofluorene (11 ).
Key words
N-acetoxy compound - LTA oxidation - α-phenyl-N -(2-aminofluorene)nitrone - dG adduct, N -(2′-deoxyguanosin-8-yl)-2-aminofluorene
References
<A NAME="RZ08701SS-1A">1a </A>
Scott TS.
Carcinogenic and Chronic Toxic Hazards of Aromatic Amines
Elsevier;
Amsterdam:
1962.
<A NAME="RZ08701SS-1B">1b </A>
Clayson DB.
Garner RC.
Chemical Carcinogens
Searle CE.
ACS Monograph 173 366;
Washington:
1969.
<A NAME="RZ08701SS-1C">1c </A>
King CM.
Glowinski IB.
EHP Environ. Health Perspect.
1983,
43:
42
<A NAME="RZ08701SS-1D">1d </A>
Lai CC.
Miller EC.
Miller JA.
Liem A.
Carcinogenesis
1988,
9:
1295
<A NAME="RZ08701SS-1E">1e </A>
Smith BA.
Springfield JR.
Gutmann HR.
Carcinogenesis
1986,
7:
405
<A NAME="RZ08701SS-1F">1f </A>
Helmick JS.
Martin KA.
Heinrich JL.
Novak M.
J. Am. Chem. Soc.
1991,
113:
3459
<A NAME="RZ08701SS-2A">2a </A>
Allaben WT.
Weis CC.
Fullerton NF.
Beland FA.
Carcinogenesis
1983,
4:
1067
<A NAME="RZ08701SS-2B">2b </A>
Morris HP.
Eyestone WH.
J. Natl. Cancer Inst.
1953,
13:
1139
<A NAME="RZ08701SS-3A">3a </A>
Lai CC.
Miller EC.
Miller JA.
Liem A.
Carcinogenesis
1988,
9:
1295
<A NAME="RZ08701SS-3B">3b </A>
Allaben WT.
King CM.
J. Biol. Chem.
1984,
259:
12128
<A NAME="RZ08701SS-4A">4a </A> In Microsomes and Drug Oxidations
Flammang TJ.
Kadlubar FF.
Taylor and Francis;
London:
1985.
p.190
<A NAME="RZ08701SS-4B">4b </A>
Flammang TJ.
Kadlubar FF.
Carcinogenesis
1986,
7:
919
<A NAME="RZ08701SS-4C">4c </A>
Bosold F.
Boche G.
Angew. Chem., Int. Ed. Engl.
1990,
29:
63
<A NAME="RZ08701SS-4D">4d </A>
Boche G.
Ulbrich R.
Famulok M.
Bosold F.
Tetrahedron Lett.
1990,
31:
1689
<A NAME="RZ08701SS-4E">4e </A>
Meier C.
Boche G.
Tetrahedron Lett.
1990,
31:
1693
<A NAME="RZ08701SS-5A">5a </A>
Scribner JA.
Miller JA.
Miller EC.
Cancer Res.
1970,
30:
1570
<A NAME="RZ08701SS-5B">5b </A>
Kriek E.
Chem. Biol. Interact.
1969,
1:
3
<A NAME="RZ08701SS-5C">5c </A>
Patel DJ.
Tonelli AF.
Biochemistry
1975,
14:
3990
<A NAME="RZ08701SS-5D">5d </A>
Graves DE.
Stone MP.
Krugh TR.
Biochemistry
1985,
24:
7573
<A NAME="RZ08701SS-6">6 </A>
Weisburger JA.
Weisburger EK.
Pharmacol. Rev.
1973,
25:
1
<A NAME="RZ08701SS-7A">7a </A>
Novak M.
Rangappa KS.
J. Org. Chem.
1992,
57:
1285
<A NAME="RZ08701SS-7B">7b </A>
Novak M.
Rangappa KS.
Manitsas RK.
J. Org. Chem.
1993,
58:
7813
<A NAME="RZ08701SS-7C">7c </A>
Novak M.
Helmick JS.
Oberlies N.
Rangappa KS.
Clark WM.
Swenton JS.
J. Org. Chem.
1993,
58:
867
<A NAME="RZ08701SS-8">8 </A>
Beland FA.
Miller DW.
Mitchum RK.
J. Chem. Soc., Chem. Commum.
1983,
30
<A NAME="RZ08701SS-9A">9a </A>
King CM.
Philipps B.
Science
1968,
159:
1351
<A NAME="RZ08701SS-9B">9b </A>
King CM.
Philipps B.
J. Biol. Chem.
1969,
244:
6209
<A NAME="RZ08701SS-10A">10a </A>
Irving CC.
Russell LT.
Biochemistry
1970,
9:
2471
<A NAME="RZ08701SS-10B">10b </A>
Lotlikar PD.
Scribner TD.
Miller JA.
Miller MC.
Life Sci.
1966,
5:
1263
<A NAME="RZ08701SS-11">11 </A>
Luha L.
Biochem. J.
1971,
124:
69
<A NAME="RZ08701SS-12">12 </A>
Weisburger JH.
Fiala ES.
Experiental Colon Carcinogenesis
CRC Press;
Boca Raton:
1979.
p.27
<A NAME="RZ08701SS-13">13 </A>
Mallesha H.
Ravi Kumar KR.
Mantelingu K.
Rangappa KS.
Synthesis
2001,
10:
1459
<A NAME="RZ08701SS-14">14 </A>
Famulok M.
Boche G.
Angew. Chem., Int. Ed. Engl.
1989,
28:
468
<A NAME="RZ08701SS-15">15 </A>
Patrick TB.
Schield JA.
Kirchner DG.
J. Org. Chem.
1974,
39:
1758
<A NAME="RZ08701SS-16">16 </A>
Mallesha H., Ravi Kumar K. R., Vishu Kumar B. K., Mantelingu K., Rangappa K. S.; Proc. Ind. Acad. Sci. (Chem. Sci.) 2001 , 113 (4 ), in press
<A NAME="RZ08701SS-17A">17a </A>
Bamberger E.
Brady F.
Berischite
1900,
33:
271
<A NAME="RZ08701SS-17B">17b </A>
Baeyer A.
Berischite
1874,
7:
1638
<A NAME="RZ08701SS-18A">18a </A>
Splitter JS.
Calvin M.
J. Org. Chem.
1958,
23:
651
<A NAME="RZ08701SS-18B">18b </A>
Kamlet MJ.
Kaplan LA.
J. Org. Chem.
1957,
22:
576
<A NAME="RZ08701SS-18C">18c </A>
Shindo H.
Umezawa B.
Chem. Pharm. Bull.
1962,
10:
492
<A NAME="RZ08701SS-19A">19a </A>
Butler RN.
Scott FL.
O’Mahony AF.
Chem. Rev.
1973,
73:
93
<A NAME="RZ08701SS-19B">19b </A>
Hamer J.
Macaluso A.
Chem. Rev.
1964,
64:
470
<A NAME="RZ08701SS-19C">19c </A>
Ohta A.
Ochai E.
Chem. Pharm. Bull.
1962,
10:
1260
<A NAME="RZ08701SS-19D">19d </A>
Ohta A.
Ochai E.
Chem. Pharm. Bull.
1963,
11:
1586
<A NAME="RZ08701SS-20">20 </A>
Tamagaki S.
Oae S.
Bull. Chem. Soc. Jpn.
1970,
43:
1573
<A NAME="RZ08701SS-21">21 </A>
Galtin L.
Davis JC.
J. Am. Chem. Soc.
1962,
84:
1464
<A NAME="RZ08701SS-22">22 </A>
Famulok M.
Bosold G.
Boche G.
Angew. Chem., Int. Ed. Engl.
1989,
28:
337
<A NAME="RZ08701SS-23">23 </A>
Underwood GR.
Price MF.
Shapiro R.
Carcinogenesis
1988,
9:
1817
<A NAME="RZ08701SS-24">24 </A>
Kriek E.
Miller JA.
Juhl U.
Miller EC.
Biochemistry
1967,
6:
177
<A NAME="RZ08701SS-25A">25a </A>
Bosold F.
Boche G.
Angew. Chem., Int. Ed. Engl.
1990,
29:
63
<A NAME="RZ08701SS-25B">25b </A>
Kriek E.
Westra JG.
Carcinogenesis
1980,
1:
459